Skip to main content
GoodMoatv1.1
Sign in
IDXX logo

IDXX

CompareEarnings: May 31, 2026

Idexx Laboratories Inc

Exchange: NASDAQSector: HealthcareIndustry: Diagnostics & Research

IDEXX Laboratories, Inc., is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolving world of veterinary medicine. We support longer, fuller lives for pets by delivering insights and solutions that help the veterinary community around the world make confident decisions—to advance medical care, improve efficiency, and build thriving practices. Our innovations also help ensure the safety of milk and water across the world and maintain the health and well-being of people and livestock. IDEXX Laboratories, Inc. is a member of the S&P 500 ® Index. Headquartered in Maine, IDEXX employs approximately 11,000 people and offers solutions and products to customers in more than 175 countries and territories.

Did you know?

Net income compounded at 16.3% annually over 6 years.

Current Price

$569.55

+0.87%

GoodMoat Value

$374.04

34.3% overvalued
Profile
Valuation (TTM)
Market Cap$45.48B
P/E42.93
EV$46.96B
P/B28.33
Shares Out79.85M
P/Sales10.57
Revenue$4.30B
EV/EBITDA30.66

Idexx Laboratories Inc (IDXX) Company Profile

GoodMoat Analysis

Based on data as of March 26, 2026

Idexx is a high-quality, high-margin business with a strong competitive moat in veterinary diagnostics, but its current valuation appears demanding. A value investor would be interested in its durable advantages and financial strength but likely find the price unfavourable without a significant margin of safety.

Read full analysis
Idexx Laboratories is a leader in veterinary diagnostics and software. It sells diagnostic equipment, consumables (like test kits), and practice management software primarily to companion animal (pet) veterinary clinics. Its business model creates a powerful recurring revenue stream: once a clinic buys its proprietary analyzer, it must continue purchasing Idexx-branded test kits and software subscriptions, locking in the customer. This drives impressive financials, with a 24.6% profit margin, 31.6% operating margin, and a stellar 66.0% Return on Equity. Using the GoodMoat framework, its moat is strong, scoring highly on Switching Costs (mission-critical, locked-in consumables), Niche Dominance (leading provider in veterinary diagnostics), and likely Brand & Culture. Its Quality Indicators are also high, with strong profitability and ROE. However, key risks for a value investor are its Valuation and Growth Deceleration. The stock trades at a P/E of 43.4, which is high for a company with 14.3% revenue growth, and the GoodMoat Target of $374.04 suggests the current price of $575.72 may lack a margin of safety. The 14.3% YoY revenue growth, while solid, must be monitored for deceleration against this premium multiple. The business is excellent, but the price presents a significant hurdle.

IDXX Company Information

IDEXX Laboratories, Inc., is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolving world of veterinary medicine. We support longer, fuller lives for pets by delivering insights and solutions that help the veterinary community around the world make confident decisions—to advance medical care, improve efficiency, and build thriving practices.

Our innovations also help ensure the safety of milk and water across the world and maintain the health and well-being of people and livestock. IDEXX Laboratories, Inc. is a member of the S&P 500 ® Index. Headquartered in Maine, IDEXX employs approximately 11,000 people and offers solutions and products to customers in more than 175 countries and territories.

Sector

Healthcare

Industry

Diagnostics & Research

Exchange

NASDAQ

Country

Maine, USA

IDXX Key Officers

Key officers data coming soon

IDXX Company Profile

Idexx Laboratories Inc (IDXX) is a Healthcare company in the Diagnostics & Research industry, listed on NASDAQ. Headquartered in Maine, USA.

IDEXX Laboratories, Inc., is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolving world of veterinary medicine. We support longer, fuller lives for pets by delivering insights and solutions that help the veterinary community around the world make confident decisions—to advance medical care, improve efficiency, and build thriving practices. Our innovations also help ensure the safety of milk and water across the world and maintain the health and well-being of people and livestock. IDEXX Laboratories, Inc. is a member of the S&P 500 ® Index. Headquartered in Maine, IDEXX employs approximately 11,000 people and offers solutions and products to customers in more than 175 countries and territories.

Market capitalization: $45.48B. Shares outstanding: 79.9M.

View the complete company profile for Idexx Laboratories Inc on GoodMoat, including key officers, financial metrics, sector classification, and investment analysis tools. Use the profile alongside GoodMoat's DCF calculator, fair value models, and quality score to evaluate whether IDXX is a sound investment opportunity.